Evidence map›Paper›PMID 35464452›Full record

ArticleFrontiers in immunology2022

Inhibition of Macrophage Migration Inhibitory Factor Activity Attenuates Haemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats.

Nikita M Patel, Noriaki Yamada, Filipe R M B Oliveira, Lara Stiehler, Elisabeth Zechendorf, Daniel Hinkelmann, Sandra Kraemer, Christian Stoppe, Massimo Collino, Debora Collotta and 8 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Nikita M PatelWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Noriaki YamadaWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Filipe R M B OliveiraDepartment of Pharmacology, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
Lara StiehlerWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Elisabeth ZechendorfDepartment of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.
Daniel HinkelmannDepartment of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.
Sandra KraemerDepartment of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.
Christian StoppeDepartment of Anesthesiology & Intensive Care Medicine, University Hospital Würzburg, Würzburg, Germany.
Massimo CollinoDepartment of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Debora CollottaDepartment of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Gustavo Ferreira AlvesDepartment of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy.
Hanna Pillmann RamosDepartment of Pharmacology, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
Regina SordiDepartment of Pharmacology, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
Ingo MarziDepartment of Trauma, Hand and Reconstructive Surgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Borna ReljaDepartment of Trauma, Hand and Reconstructive Surgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
Gernot MarxDepartment of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.
Lukas MartinWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Christoph ThiemermannWilliam Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study was to investigate (a) macrophage migration inhibitory factor (MIF) levels in polytrauma patients and rats after haemorrhagic shock (HS), (b) the potential of the MIF inhibitor ISO-1 to reduce multiple organ dysfunction syndrome (MODS) in acute (short-term and long-term follow-up) HS rat models and (c) whether treatment with ISO-1 attenuates NF-κB and NLRP3 activation in HS. Background: The MODS caused by an excessive systemic inflammatory response following trauma is associated with a high morbidity and mortality. MIF is a pleiotropic cytokine which can modulate the inflammatory response, however, its role in trauma is unknown. Methods: The MIF levels in plasma of polytrauma patients and serum of rats with HS were measured by ELISA. Acute HS rat models were performed to determine the influence of ISO-1 on MODS. The activation of NF-κB and NLRP3 pathways were analysed by western blot in the kidney and liver. Results: We demonstrated that (a) MIF levels are increased in polytrauma patients on arrival to the emergency room and in rats after HS, (b) HS caused organ injury and/or dysfunction and hypotension (post-resuscitation) in rats, while (c) treatment of HS-rats with ISO-1 attenuated the organ injury and dysfunction in acute HS models and (d) reduced the activation of NF-κB and NLRP3 pathways in the kidney and liver. Conclusion: Our results point to a role of MIF in the pathophysiology of trauma-induced organ injury and dysfunction and indicate that MIF inhibitors may be used as a potential therapeutic approach for MODS after trauma and/or haemorrhage.

Indexed as

Macrophage Migration-Inhibitory FactorsMultiple TraumaShock, HemorrhagicAnimalsHumansMultiple Organ FailureNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinRatsMacrophage Migration-Inhibitory FactorsNF-kappa BNLR Family, Pyrin Domain-Containing 3 Proteinhaemorrhagic shockischaemia-reperfusionISO-1macrophage migration inhibitory factormultiple organ dysfunction syndrometrauma

Identifiers

PMID35464452
PMCPMC9019168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.